A Qualitative Study Comparing the Assay Performance Characteristics Between the 2007 and the 2013 American Society for Clinical Oncology and College of American Pathologists HER2 Scoring Methods in Mucinous Epithelial Ovarian Cancer

The remarkable success of trastuzumab and other newly developed anti-HER2 (human epidermal growth factor receptor 2) therapies in breast, gastric, or gastroesophageal junction cancer patients has supported us to investigate the HER2 status and its possible therapeutic implication in mucinous epithel...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chi-Kuan, Lee, Ming-Yung, Lin, Wea-Lung, Wang, Yu-Ting, Han, Chih-Ping, Yu, Cheng-Ping, Chao, Wan-Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602799/
https://www.ncbi.nlm.nih.gov/pubmed/25501060
http://dx.doi.org/10.1097/MD.0000000000000171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602799/
https://www.ncbi.nlm.nih.gov/pubmed/25501060
http://dx.doi.org/10.1097/MD.0000000000000171

Ejemplares similares